EN Official Journal of the European Union C 347/19

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2015

(2016/C 347/05)

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2015, at their meeting on 18 March 2016:

Annex I List of new marketing authorisations Annex II List of renewed marketing authorisations Annex III List of extended marketing authorisations Annex IV List of withdrawn marketing authorisations Annex V List of suspended marketing authorisations

ANNEX I List of new marketing authorisations The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2015: EU Number Product Country Date of authorisation EU/1/11/710 Votubia (switch to non-conditional) Liechtenstein 31.12.2015 EU/1/13/895 Kolbam Iceland 14.12.2015 EU/1/13/895 Kolbam Norway 15.12.2015 EU/1/13/895 Kolbam Liechtenstein 31.12.2015 EU/1/15/1005 Aripiprazole Pharmathen Iceland 23.7.2015 EU/1/15/1005 Aripiprazole Pharmathen Liechtenstein 31.8.2015 EU/1/15/1005 Aripiprazole Pharmathen Norway 16.7.2015 EU/1/15/1006 Respreeza Iceland 31.8.2015 EU/1/15/1006 Respreeza Liechtenstein 31.8.2015 EU/1/15/1006 Respreeza Norway 28.8.2015 EU/1/15/1007 Gardasil 9 Iceland 8.7.2015 EU/1/15/1008 Hetlioz Iceland 4.8.2015 EU/1/15/1008 Hetlioz Liechtenstein 31.8.2015 EU/1/15/1008 Hetlioz Norway 16.7.2015 EU/1/15/1009 Aripiprazole Zentiva Iceland 23.7.2015 EU/1/15/1009 Aripiprazole Zentiva Norway 16.7.2015 EU/1/15/1010 Duloxetine Mylan Iceland 9.7.2015 EU/1/15/1010 Duloxetine Mylan Norway 9.7.2015 EU/1/15/1011 Pregabalin Sandoz Iceland 10.7.2015 EU/1/15/1011 Pregabalin Sandoz Norway 17.7.2015 EU/1/15/1012 Pregabalin Sandoz GmbH Iceland 10.7.2015 EU/1/15/1012 Pregabalin Sandoz GmbH Norway 17.7.2015 EU/1/15/1013 Lumark Norway 13.7.2015 EU/1/15/1013 Lumark Iceland 10.7.2015 EU/1/15/1014 OPDIVO Iceland 10.7.2015 EU/1/15/1014 Opdivo Norway 2.7.2015 EU/1/15/1015 Strensiq Iceland 10.9.2015 EU/1/15/1015 Strensiq Liechtenstein 31.10.2015 EU/1/15/1015 Strensiq Norway 14.9.2015 EU/1/15/1016 Repatha Iceland 14.8.2015 EU/1/15/1016 Repatha Liechtenstein 31.8.2015 EU/1/15/1016 Repatha Norway 5.8.2015 EU/1/15/1017 Docetaxel Hospira UK Limited Iceland 4.9.2015 EU/1/15/1017 Docetaxel Hospira UK limited Liechtenstein 31.10.2015 EU/1/15/1017 Docetaxel Hospira UK Limited Norway 7.9.2015 EU/1/15/1018 Omidria Iceland 19.8.2015 EU/1/15/1018 Omidria Liechtenstein 31.8.2015 EU/1/15/1018 Omidria Norway 26.8.2015 EU/1/15/1019 Bortezomib Accord Iceland 19.8.2015 EU/1/15/1019 Bortezomib Accord Liechtenstein 31.8.2015 EU/1/15/1019 Bortezomib Accord Norway 11.8.2015 EU/1/15/1020 Raxone Iceland 15.9.2015 EU/1/15/1020 Raxone Liechtenstein 31.10.2015 EU/1/15/1020 Raxone Norway 30.9.2015 EU/1/15/1021 Pregabalin Zentiva Iceland 14.8.2015 EU/1/15/1021 Pregabalin Zentiva Liechtenstein 31.8.2015 EU/1/15/1021 Pregabalin Zentiva Norway 10.8.2015 EU/1/15/1022 Unituxin Iceland 21.8.2015 EU/1/15/1022 Unituxin Liechtenstein 31.8.2015 EU/1/15/1022 Unituxin Norway 25.8.2015 EU/1/15/1023 Farydak Iceland 4.9.2015 EU/1/15/1023 Farydak Liechtenstein 31.10.2015 EU/1/15/1023 Farydak Norway 7.9.2015 EU/1/15/1024 Keytruda Iceland 13.8.2015 EU/1/15/1024 Keytruda Liechtenstein 31.8.2015 EU/1/15/1024 Keytruda Norway 11.8.2015 EU/1/15/1025 Evotaz Iceland 12.8.2015 EU/1/15/1025 Evotaz Liechtenstein 31.8.2015 EU/1/15/1025 Evotaz Norway 10.8.2015 EU/1/15/1026 Nivolumab BMS Iceland 28.12.2015 EU/1/15/1026 Nivolumab BMS Liechtenstein 31.8.2015 EU/1/15/1026 Nivolumab BMS Norway 11.8.2015 EU/1/15/1027 Pregabalin Accord Iceland 2.9.2015 EU/1/15/1027 Pregabalin Accord Liechtenstein 31.10.2015 EU/1/15/1027 Pregabalin Accord Norway 7.9.2015 EU/1/15/1028 Duloxetine Zentiva Iceland 31.8.2015 EU/1/15/1028 Duloxetine Zentiva Liechtenstein 31.8.2015 EU/1/15/1028 Duloxetine Zentiva Norway 23.9.2015 EU/1/15/1029 Aripiprazole Sandoz Iceland 31.8.2015 EU/1/15/1029 Aripiprazole Sandoz Liechtenstein 31.8.2015 EU/1/15/1029 Aripiprazole Sandoz Norway 25.8.2015 EU/1/15/1030 Odomzo Iceland 1.9.2015 EU/1/15/1030 Odomzo Liechtenstein 31.8.2015 EU/1/15/1030 Odomzo Norway 4.9.2015 EU/1/15/1031 Praluent Iceland 16.10.2015 EU/1/15/1031 Praluent Liechtenstein 31.10.2015 EU/1/15/1031 Praluent Norway 1.10.2015 EU/1/15/1032 Zerbaxa Iceland 23.9.2015 EU/1/15/1032 Zerbaxa Liechtenstein 31.10.2015 EU/1/15/1032 Zerbaxa Norway 13.10.2015 EU/1/15/1033 Kanuma Iceland 2.9.2015 EU/1/15/1033 Kanuma Liechtenstein 31.8.2015 EU/1/15/1033 Kanuma Norway 10.9.2015 EU/1/15/1034 Pemetrexed Lilly Iceland 21.9.2015 EU/1/15/1034 Pemetrexed Lilly Liechtenstein 31.10.2015 EU/1/15/1034 Pemetrexed Lilly Norway 21.9.2015 EU/1/15/1035 Obizur Iceland 18.11.2015 EU/1/15/1035 Obizur Norway 30.11.2015 EU/1/15/1035 Obizur Liechtenstein 31.12.2015 EU/1/15/1036 Cresemba Iceland 23.10.2015 EU/1/15/1036 Cresemba Liechtenstein 31.10.2015 EU/1/15/1036 Cresemba Norway 11.11.2015 EU/1/15/1037 Pemetrexed Sandoz Iceland 15.10.2015 EU/1/15/1037 Pemetrexed Sandoz Liechtenstein 31.10.2015 EU/1/15/1037 Pemetrexed Sandoz Norway 24.9.2015 EU/1/15/1038 Pemetrexed medac Iceland 11.12.2015 EU/1/15/1038 Pemetrexed medac Norway 14.12.2015 EU/1/15/1038 Pemetrexed medac Liechtenstein 31.12.2015 EU/1/15/1039 Fexeric Iceland 16.10.2015 EU/1/15/1039 Fexeric Liechtenstein 31.10.2015 EU/1/15/1039 Fexeric Norway 13.10.2015 EU/1/15/1040 Intuniv Iceland 21.9.2015 EU/1/15/1040 Intuniv Liechtenstein 31.10.2015 EU/1/15/1040 Intuniv Norway 23.9.2015 EU/1/15/1041 Ivabradine Anpharm Iceland 15.10.2015 EU/1/15/1041 Ivabradine Anpharm Liechtenstein 31.10.2015 EU/1/15/1041 Ivabradine Anpharm Norway 1.10.2015 EU/1/15/1042 Zalviso Liechtenstein 31.10.2015 EU/1/15/1042 Zalviso Iceland 16.10.2015 EU/1/15/1042 Zalviso Norway 13.10.2015 EU/1/15/1043 Nucala Iceland 29.12.2015 EU/1/15/1043 Nucala Norway 10.12.2015 EU/1/15/1043 Nucala Liechtenstein 31.12.2015 EU/1/15/1044 Numient Iceland 14.12.2015 EU/1/15/1044 Numient Norway 22.12.2015 EU/1/15/1044 Numient Liechtenstein 31.12.2015 EU/1/15/1045 Aripiprazole Accord Iceland 20.11.2015 EU/1/15/1045 Aripiprazole Accord Norway 3.12.2015 EU/1/15/1045 Aripiprazole Accord Liechtenstein 31.12.2015 EU/1/15/1046 Elocta Iceland 11.12.2015 EU/1/15/1046 Elocta Norway 17.12.2015 EU/1/15/1046 Elocta Liechtenstein 31.12.2015 EU/1/15/1047 Blincyto Iceland 23.12.2015 EU/1/15/1047 Blincyto Norway 1.12.2015 EU/1/15/1047 Blincyto Liechtenstein 31.12.2015 EU/1/15/1048 Cotellic Iceland 11.12.2015 EU/1/15/1048 Cotellic Norway 30.11.2015 EU/1/15/1048 Cotellic Liechtenstein 31.12.2015 EU/1/15/1050 Ionsys Iceland 24.11.2015 EU/1/15/1050 Ionsys Norway 10.12.2015 EU/1/15/1050 Ionsys Liechtenstein 31.12.2015 EU/1/15/1051 Ebymect Iceland 23.11.2015 EU/1/15/1051 Ebymect Norway 10.12.2015 EU/1/15/1051 Ebymect Liechtenstein 31.12.2015 EU/1/15/1052 Edistride Iceland 17.11.2015 EU/1/15/1052 Edistride Norway 3.12.2015 EU/1/15/1052 Edistride Liechtenstein 31.12.2015 EU/1/15/1054 Cinacalcet Mylan Iceland 24.11.2015 EU/1/15/1054 Cinacalcet Mylan Norway 30.11.2015 EU/1/15/1054 Cinacalcet Mylan Liechtenstein 31.12.2015 EU/1/15/1055 Ciambra Iceland 29.12.2015 EU/1/15/1055 Ciambra Norway 10.12.2015 EU/1/15/1055 Ciambra Liechtenstein 31.12.2015 EU/1/15/1056 Praxbind Iceland 11.12.2015 EU/1/15/1056 Praxbind Norway 10.12.2015 EU/1/15/1056 Praxbind Liechtenstein 31.12.2015 EU/1/15/1057 Pemetrexed Hospira Iceland 11.12.2015 EU/1/15/1057 Pemetrexed Hospira Norway 1.12.2015 EU/1/15/1057 Pemetrexed Hospira Liechtenstein 31.12.2015 EU/1/15/1058 Entresto Iceland 11.12.2015 EU/1/15/1058 Entresto Norway 26.11.2015 EU/1/15/1058 Entresto Liechtenstein 31.12.2015 EU/1/15/1059 Orkambi Iceland 8.12.2015 EU/1/15/1059 Orkambi Norway 10.12.2015 EU/1/15/1059 Orkambi Liechtenstein 31.12.2015 EU/1/15/1060 Kyprolis Iceland 24.11.2015 EU/1/15/1060 Kyprolis Norway 1.12.2015 EU/1/15/1060 Kyprolis Liechtenstein 31.12.2015 EU/1/15/1061 Genvoya Iceland 9.12.2015 EU/1/15/1061 Genvoya Norway 10.12.2015 EU/1/15/1061 Genvoya Liechtenstein 31.12.2015 EU/1/15/1062 Ravicti Iceland 15.12.2015 EU/1/15/1062 Ravicti Norway 10.12.2015 EU/1/15/1062 Ravicti Liechtenstein 31.12.2015 EU/1/15/993 Lixiana Iceland 10.7.2015 EU/1/15/993 Lixiana Norway 6.7.2015 EU/1/15/997 Pregabalin Mylan Iceland 13.7.2015 EU/1/15/997 Pregabalin Mylan Liechtenstein 31.8.2015 EU/1/15/997 Pregabalin Mylan Norway 16.7.2015 EU/1/15/998 Pregabalin Mylan Pharma Iceland 13.7.2015 EU/1/15/998 Pregabalin Mylan Pharma Liechtenstein 31.8.2015 EU/1/15/998 Pregabalin Mylan Pharma Norway 16.7.2015 EU/2/15/181 Sileo Iceland 8.7.2015 EU/2/15/182 Innovax ILT Liechtenstein 31.8.2015 EU/2/15/182 Innovax-ILT Iceland 24.7.2015 EU/2/15/182 Innovax-ILT Norway 30.7.2015 EU/2/15/183 Canigen L4 Iceland 6.8.2015 EU/2/15/183 Canigen L4 Liechtenstein 31.8.2015 EU/2/15/183 Canigen L4 Norway 30.7.2015 EU/2/15/184 UpCard Iceland 20.8.2015 EU/2/15/184 UpCard Liechtenstein 31.10.2015 EU/2/15/184 UpCard Norway 10.8.2015 EU/2/15/185 Fortekor Plus Iceland 21.9.2015 EU/2/15/185 Fortekor Plus Liechtenstein 31.10.2015 EU/2/15/185 Fortekor Plus Norway 6.10.2015 EU/2/15/186 Novaquin Iceland 15.9.2015 EU/2/15/186 Novaquin Liechtenstein 31.10.2015 EU/2/15/186 Novaquin Norway 6.10.2015 EU/2/15/187 Porcilis PCV ID Iceland 2.9.2015 EU/2/15/187 Porcilis PCV ID Liechtenstein 31.10.2015 EU/2/15/187 Porcilis PCV ID Norway 9.9.2015 EU/2/15/188 Vectormune ND Iceland 21.9.2015 EU/2/15/188 Vectormune ND Liechtenstein 31.10.2015 EU/2/15/188 Vectormune ND Norway 6.10.2015 EU/2/15/189 Zycortal Iceland 20.11.2015 EU/2/15/189 Zycortal Norway 3.12.2015 EU/2/15/189 Zycortal Liechtenstein 31.12.2015 EU/2/15/190 Suvaxyn Circo + MH RTU Norway 4.12.2015 EU/2/15/190 Suvaxyn Circo + MH RTU Liechtenstein 31.12.2015 EU/2/15/190 Suvaxyn Circo + MH RTU Iceland 16.11.2015 EU/2/15/191 Simparica Iceland 20.11.2015 EU/2/15/191 Simparica Norway 4.12.2015 EU/2/15/191 Simparica Liechtenstein 31.12.2015 EU/2/15/192 Velactis Iceland 30.12.2015 EU/2/15/192 Velactis Liechtenstein 31.12.2015 EU/2/15/193 Imrestor Liechtenstein 31.12.2015

ANNEX II List of renewed marketing authorisations The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2015: EU Number Product Country Date of authorisation EU/1/00/146 Keppra Iceland 31.8.2015 EU/1/00/146 Keppra Liechtenstein 31.10.2015 EU/1/00/146 Keppra Norway 8.9.2015 EU/1/05/310 Fosavance Iceland 24.8.2015 EU/1/05/312 Xyrem Iceland 15.10.2015 EU/1/05/312 Xyrem Liechtenstein 31.10.2015 EU/1/05/312 Xyrem Norway 14.10.2015 EU/1/05/315 Aptivus Iceland 10.7.2015 EU/1/05/315 Aptivus Norway 2.7.2015 EU/1/05/319 Xolair Iceland 9.7.2015 EU/1/05/319 Xolair Norway 7.7.2015 EU/1/05/323 ProQuad Liechtenstein 31.12.2015 EU/1/05/325 Macugen Iceland 9.12.2015 EU/1/05/325 Macugen Norway 30.11.2015 EU/1/05/325 Macugen Liechtenstein 31.12.2015 EU/1/10/639 Telmisartan Actavis Iceland 9.7.2015 EU/1/10/639 Telmisartan Actavis Norway 8.7.2015 EU/1/10/641 Ruconest Iceland 16.10.2015 EU/1/10/641 Ruconest Norway 14.10.2015 EU/1/10/641 Ruconest Liechtenstein 31.12.2015 EU/1/10/642 Ibandronic Acid Teva Iceland 9.7.2015 EU/1/10/642 Ibandronic Acid Teva Norway 16.7.2015 EU/1/10/644 PecFent Iceland 27.8.2015 EU/1/10/644 PecFent Norway 10.8.2015 EU/1/10/645 Brinavess Iceland 19.8.2015 EU/1/10/645 Brinavess Liechtenstein 31.8.2015 EU/1/10/645 Brinavess Norway 26.8.2015 EU/1/10/646 VPRIV Iceland 9.7.2015 EU/1/10/646 VPRIV Norway 7.7.2015 EU/1/10/648 Twynsta Iceland 1.9.2015 EU/1/10/648 Twynsta Liechtenstein 31.10.2015 EU/1/10/648 Twynsta Norway 8.9.2015 EU/1/10/651 Clopidogrel HCS Iceland 9.7.2015 EU/1/10/651 Clopidogrel HCS Norway 1.7.2015 EU/1/10/654 Leflunomide ratiopharm Iceland 10.7.2015 EU/1/10/654 Leflunomide ratiopharm Norway 2.7.2015 EU/1/10/655 Brilique Iceland 13.8.2015 EU/1/10/655 Brilique Liechtenstein 31.8.2015 EU/1/10/655 Brilique Norway 26.8.2015 EU/1/10/658 Aflunov Iceland 13.8.2015 EU/1/10/658 Aflunov Liechtenstein 31.8.2015 EU/1/10/658 Aflunov Norway 14.8.2015 EU/1/10/659 Iasibon Norway 20.10.2015 EU/1/10/659 Iasibon Iceland 14.10.2015 EU/1/10/659 Iasibon Liechtenstein 31.10.2015 EU/1/10/660 Potactasol Iceland 22.10.2015 EU/1/10/660 Potactasol Liechtenstein 31.10.2015 EU/1/10/660 Potactasol Norway 16.10.2015 EU/1/10/663 Lamivudine/Zidovudine Teva Norway 10.12.2015 EU/1/10/663 Lamivudine/Zidovudine Teva Iceland 9.12.2015 EU/1/10/663 Lamivudine/Zidovudine Teva Liechtenstein 31.12.2015 EU/1/10/665 Entacapone Teva Iceland 10.12.2015 EU/1/10/665 Entacapone Teva Norway 10.12.2015 EU/1/10/665 Entacapone Teva Liechtenstein 31.12.2015 EU/1/11/667 Esbriet Iceland 15.9.2015 EU/1/11/667 Esbriet Liechtenstein 31.10.2015 EU/1/11/667 Esbriet Norway 16.9.2015 EU/1/11/669 Teysuno Iceland 8.12.2015 EU/1/11/669 Teysuno Norway 1.12.2015 EU/1/11/669 Teysuno Liechtenstein 31.12.2015 EU/1/11/672 Xeplion Liechtenstein 31.12.2015 EU/1/11/673 Ifirmacombi Iceland 10.12.2015 EU/1/11/673 Ifirmacombi Norway 30.11.2015 EU/1/11/673 Ifirmacombi Liechtenstein 31.12.2015 EU/1/11/676 Jevtana Iceland 10.12.2015 EU/1/11/676 Jevtana Norway 27.11.2015 EU/1/11/676 Jevtana Liechtenstein 31.12.2015 EU/1/11/677 Gilenya Iceland 8.12.2015 EU/1/11/677 Gilenya Norway 27.11.2015 EU/1/11/678 Halaven Iceland 9.12.2015 EU/1/11/678 Halaven Norway 27.11.2015 EU/1/11/678 Halaven Liechtenstein 31.12.2015 EU/1/11/699 Fampyra Iceland 25.8.2015 EU/1/11/699 Fampyra Liechtenstein 31.8.2015 EU/1/11/699 Fampyra Norway 3.8.2015 EU/1/11/710 Votubia Iceland 19.8.2015 EU/1/11/710 Votubia Liechtenstein 31.8.2015 EU/1/11/710 Votubia Norway 14.8.2015 EU/1/12/793 Xalkori Iceland 13.8.2015 EU/1/12/793 Xalkori Liechtenstein 31.8.2015 EU/1/12/793 Xalkori Norway 17.8.2015 EU/1/12/794 Adcetris Iceland 15.10.2015 EU/1/12/794 Adcetris Norway 30.9.2015 EU/1/12/794 Adcetris Liechtenstein 31.12.2015 EU/1/13/902 Translarna Iceland 19.8.2015 EU/1/13/902 Translarna Liechtenstein 31.8.2015 EU/1/13/902 Translarna Norway 26.8.2016 EU/1/14/987 Holoclar Norway 17.12.2015 EU/1/14/987 Holoclar Liechtenstein 31.12.2015 EU/2/05/055 Equilis Te Iceland 9.7.2015 EU/2/10/108 BTVPUR AlSap 2-4 Iceland 20.8.2015 EU/2/10/108 BTVPUR AlSap 2-4 Liechtenstein 31.8.2015 EU/2/10/108 BTVPUR AlSap 2-4 Norway 10.8.2015 EU/2/10/109 Rhiniseng Iceland 23.7.2015 EU/2/10/109 Rhiniseng Norway 29.7.2015 EU/2/10/110 Coxevac Iceland 20.8.2015 EU/2/10/110 Coxevac Liechtenstein 31.8.2015 EU/2/10/110 Coxevac Norway 13.8.2015 EU/2/10/111 Meloxoral Iceland 15.9.2015 EU/2/10/111 Meloxoral Liechtenstein 31.10.2015 EU/2/10/111 Meloxoral Norway 6.10.2015 EU/2/10/112 BTVPUR ALSap 1 Iceland 15.9.2015 EU/2/10/112 BTVPUR AlSap 1 Liechtenstein 31.10.2015 EU/2/10/112 BTVPUR AlSap 1 Norway 6.10.2015 EU/2/10/113 BTVPUR ALSap 1-8 Iceland 15.9.2015 EU/2/10/113 BTVPUR AlSap 1-8 Norway 6.10.2015 EU/2/10/114 Hiprabovis IBR Marker Live Iceland 20.11.2015 EU/2/10/114 Hiprabovis IBR Marker Live Norway 3.12.2015 EU/2/10/114 Hiprabovis IBR Marker Live Liechtenstein 31.12.2015 EU/2/10/117 Purevax Rabies Iceland 30.12.2015 EU/2/10/117 Purevax Rabies Norway 18.12.2015 EU/2/10/117 Purevax Rabies Liechtenstein 31.12.2015

ANNEX III List of extended marketing authorisations The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2015: EU Number Product Country Date of authorisation EU/1/02/240/009-012 Somavert Iceland 13.8.2015 EU/1/02/240/009-012 Somavert Norway 6.8.2015 EU/1/04/303/005 Orfadin Iceland 10.7.2015 EU/1/04/303/005 Orfadin Norway 13.7.2015 EU/1/06/359/005-006 Suboxone Iceland 20.11.2015 EU/1/06/359/005-006 Suboxone Norway 3.12.2015 EU/1/12/782/003-004 Kalydeco Iceland 8.12.2015 EU/1/12/782/003-004 Kalydeco Norway 10.12.2015 EU/1/12/782/006 Iclusig Norway 14.12.2015 EU/1/13/839/006 Iclusig Iceland 23.12.2015 EU/1/96/016/009 Norvir Iceland 2.9.2015 EU/1/96/016/009 Norvir Norway 8.9.2015 EU/2/11/134/021 Inflacam Iceland 30.12.2015 EU/2/11/134/021 Inflacam Norway 30.12.2015

ANNEX IV List of withdrawn marketing authorisations The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2015: EU Number Product Country Date of authorisation EU/1/01/179 Osigraft Liechtenstein 31.12.2015 EU/1/08/450 Biograstim Iceland 22.10.2015 EU/1/08/450 Biograstim Liechtenstein 31.10.2015 EU/1/08/450 Biograstim Norway 7.10.2015 EU/1/08/452 Pandemrix Iceland 17.11.2015 EU/1/11/686 Rasilamlo Iceland 23.7.2015 EU/1/11/686 Rasilamlo Norway 18.8.2015 EU/1/14/912 Zoledronic acid Teva Generics Iceland 12.8.2015 EU/1/14/912 Zoledronic acid Teva Generics Norway 25.9.2015 EU/1/15/1026 Nivolumab BMS Iceland 28.12.2015 EU/1/15/1026 Nivolumab BMS Norway 9.12.2015 EU/1/15/1026 Nivolumab BMS Liechtenstein 31.12.2015 EU/1/99/102 Sonata Iceland 6.8.2015 EU/1/99/102 Sonata Liechtenstein 31.8.2015 EU/1/99/102 Sonata Norway 18.8.2015 EU/2/06/064 ProMeris Iceland 7.8.2015 EU/2/06/064 ProMeris Liechtenstein 31.8.2015 EU/2/06/064 ProMeris Norway 18.8.2015 EU/2/06/065 ProMeris Duo Iceland 7.8.2015 EU/2/06/065 ProMeris Duo Liechtenstein 31.8.2015 EU/2/06/065 ProMeris Duo Norway 26.8.2015 EU/2/97/003 Dicural Iceland 6.11.2015 EU/2/97/003 Dicural Liechtenstein 31.10.2015 EU/2/97/003 Dicural Norway 1.12.2015